Literature DB >> 19002937

Use of hollow fiber systems for rapid and direct scale up of antibody production from hybridoma cell lines cultured in CL-1000 flasks using BD Cell MAb medium.

Michael J Gramer1, Jodi Maas, Michael M Lieberman.   

Abstract

The combination of BD Cell MAb medium with the CL-1000 flask is increasingly being used to generate a few hundred milligram of antibody for early stage research projects. Cells are inoculated at 2 million per ml, and the antibody is harvested after 15 days or when the antibody concentration reaches above 10 mg ml(-1), whichever comes first. Currently, there is no means to scale up beyond this production level using this technology. In this study, we evaluated hollow fiber technology as the scale up alternative. The hollow fiber system was run in batch mode to mimic the method used for the CL-1000 with BD MAb medium. The FL-NS murine hybridoma cell line was simultaneously inoculated at 2 million cells per ml in a CL-1000 and the Maximizer hollow fiber bioreactor system, a 21-fold theoretical scale up over the CL-1000. The Maximizer produced 23-fold more antibody, very close to the expected theoretical amount. However, production was complete after 9 days in the Maximizer, while the CL-1000 required the full 15 days for production. In summary, these results demonstrate successful scale up of antibody production from the CL-1000 to a hollow fiber system.

Entities:  

Year:  2003        PMID: 19002937      PMCID: PMC3449449          DOI: 10.1023/B:CYTO.0000015842.54956.24

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  6 in total

1.  Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology.

Authors:  M Trebak; J M Chong; D Herlyn; D W Speicher
Journal:  J Immunol Methods       Date:  1999-11-19       Impact factor: 2.303

2.  Effect of harvesting protocol on performance of a hollow fiber bioreactor.

Authors:  M J Gramer; D M Poeschl; M J Conroy; B E Hammer
Journal:  Biotechnol Bioeng       Date:  1999-11-05       Impact factor: 4.530

3.  Antibody production by a hybridoma cell line at high cell density is limited by two independent mechanisms.

Authors:  Michael J Gramer; Tracey L Britton
Journal:  Biotechnol Bioeng       Date:  2002-08-05       Impact factor: 4.530

4.  Model of oxygen transport limitations in hollow fiber bioreactors.

Authors:  J M Piret; C L Cooney
Journal:  Biotechnol Bioeng       Date:  1991-01-05       Impact factor: 4.530

5.  A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: effect of nutrient concentration, dilution rate, and pH.

Authors:  W M Miller; H W Blanch; C R Wilke
Journal:  Biotechnol Bioeng       Date:  1988-10-05       Impact factor: 4.530

6.  Screening tool for hollow-fiber bioreactor process development

Authors: 
Journal:  Biotechnol Prog       Date:  1998-03
  6 in total
  1 in total

1.  Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production.

Authors:  Gwendal Gränicher; Felipe Tapia; Ilona Behrendt; Ingo Jordan; Yvonne Genzel; Udo Reichl
Journal:  Biotechnol J       Date:  2020-09-08       Impact factor: 5.726

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.